Ascendis Pharma A/S is a Danish A/S based in Hellerup, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2006, the company has 669 employees and reported revenue of 458,3 mio. kr. in its latest annual filing.
Selskabet tegnes af bestyrelsens formand i forening med en direktør, af to direktører i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at udvikle idèer og præparater til sygdomsbekæmpelse ad medicinsk vej, at producere og sælge sådanne præparater eller idèer, at eje aktier i selskaber med samme formål samt at udøve virksomhed, som står i naturlig forbindelse hermed.
In its most recent annual report (2025), Ascendis Pharma A/S reported revenue of 458,3 mio. kr., an increase of 13% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of 58,5 mio. kr., and the EBITDA margin stood at 0.9%.
At the end of 2025, equity financed 76.4% of the balance sheet, and current assets covered short-term debt 1.2 times.
Frequently asked questions
What is the CVR number of Ascendis Pharma A/S?
Ascendis Pharma A/S is registered with CVR / Virk under CVR 29918791.
What is the revenue of Ascendis Pharma A/S?
Ascendis Pharma A/S reported revenue of 458,3 mio. kr. in 2025.
How many employees does Ascendis Pharma A/S have?
Ascendis Pharma A/S employs 669 people as of the latest annual report.
Who is the CEO of Ascendis Pharma A/S?
Jan Møller Mikkelsen is the CEO of Ascendis Pharma A/S, in role since 2007.
Who is the chairman of Ascendis Pharma A/S?
Albert Cha chairs the board of Ascendis Pharma A/S, in role since 2021.
Where is Ascendis Pharma A/S headquartered?
Ascendis Pharma A/S's registered address is Tuborg Boulevard 12.
